NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET® pulse ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the ...
These promising results-from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population-add to previously published evidence of its strong ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...
In the latest retrospective analysis, the study’s investigators paid particular attention to each patient’s perfusion pressure, denoting how effectively blood is being pushed throughout the body. They ...
Stateside, the ORi sensor will be available in several of Masimo’s RD Rainbow pulse oximetry devices: a newly launched one that features four LED sensors and can calculate both oxygen saturation and ...
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results